Outpatient Epcoritamab in Large B-cell Lymphoma
Outpatient Epcoritamab in Large B-cell Lymphoma
Recruiting · NCT06811272 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Outpatient Epcoritamab in Large B-cell Lymphoma | Refractory Large B-cell Lymphoma; Relapsed Large B-cell Lymphoma | Recruiting | Phase 2 | 2026-08-13 | NCT06811272 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genmab | 54 |
| Massachusetts General Hospital | 758 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| Newton-Wellesley Hospital | Newton | United States | 20 |